These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neuromuscular abnormalities in the major mental illnesses. I. Serum enzyme studies. Meltzer HY Res Publ Assoc Res Nerv Ment Dis; 1975; 54():165-88. PubMed ID: 1219949 [TBL] [Abstract][Full Text] [Related]
4. Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients. Lerner P; Goodwin FK; van Kammen DP; Post RM; Major LF; Ballenger JC; Lovenberg W Biol Psychiatry; 1978 Dec; 13(6):685-94. PubMed ID: 737256 [TBL] [Abstract][Full Text] [Related]
5. Creatine phosphokinase elevations and psychiatric symptomatology. Taylor JR; Abichandani L Biol Psychiatry; 1980 Dec; 15(6):865-70. PubMed ID: 7459407 [TBL] [Abstract][Full Text] [Related]
6. Muscle abnormalities in psychotic patients. II. Serum CPK activity, fiber abnormalities, and branching and sprouting of subterminal nerves. Meltzer HY; Crayton JW Biol Psychiatry; 1974 Apr; 8(2):191-208. PubMed ID: 4842377 [No Abstract] [Full Text] [Related]
7. [Behavior of serum CPK (creatine phosphokinase) and aldolase levels in psychiatric patients]. Tropeano G; Del Vecchio M; Amati A; Cocorullo M; Kemali D Acta Neurol (Napoli); 1972; 27(4):386-94. PubMed ID: 5085163 [No Abstract] [Full Text] [Related]
8. [The significance of changed monoamine oxidases in patients with psychiatric diseases]. Demisch L Nervenarzt; 1982 Aug; 53(8):455-60. PubMed ID: 7133246 [No Abstract] [Full Text] [Related]
9. Effects of isometric exercise on serum creatine phosphokinase activity. Goode DJ; Meltzer HY Arch Gen Psychiatry; 1976 Oct; 33(10):1207-11. PubMed ID: 971030 [TBL] [Abstract][Full Text] [Related]
10. [Serum creatinphosphokinase (CPK) in endogenic psychoses]. Krüger E; Lohse H Psychiatr Neurol Med Psychol (Leipz); 1975 Mar; 27(3):140-6. PubMed ID: 1197451 [TBL] [Abstract][Full Text] [Related]
11. Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients. Segal M; Avital A; Drobot M; Lukanin A; Derevenski A; Sandbank S; Weizman A Eur Neuropsychopharmacol; 2007 Feb; 17(3):194-8. PubMed ID: 17049435 [TBL] [Abstract][Full Text] [Related]
12. Serum dopamine- -hydroxylase (D H) activity and affective states. Shopsin B; Freedman LS; Goldstein M; Gershon S Psychopharmacologia; 1972; 27(1):11-6. PubMed ID: 5081366 [No Abstract] [Full Text] [Related]
13. Psychomotor activity and serum creatine phosphokinase activity. Foster FG; Kupfer DJ Arch Gen Psychiatry; 1973 Dec; 29(6):752-8. PubMed ID: 4751815 [No Abstract] [Full Text] [Related]
15. [A study on serum creatine phosphokinase and type A behavior in schizophrenia]. Wu YB Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):177-8, backcover. PubMed ID: 2591274 [TBL] [Abstract][Full Text] [Related]
16. Neuromuscular abnormalities in the major mental illnesses. II. Muscle fiber and subterminal motor nerve abnormalities. Meltzer HY; Crayton JW Res Publ Assoc Res Nerv Ment Dis; 1975; 54():189-207. PubMed ID: 1219950 [No Abstract] [Full Text] [Related]
17. [Formulating a diagnosis in psychiatry]. Schützwohl M; Häfner-Ranabauer W Nervenarzt; 1994 Mar; 65(3):149-55. PubMed ID: 8177354 [TBL] [Abstract][Full Text] [Related]